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1. INTRODUCTION 
Urolithiasis and renal colics are very common around the world. In fact, we´ve often 
seen this suffering among family members, friends or close acquaintances and all of 
them used similar words to describe its pain: a severe, unbearable or excruciating 
pain in the flank. Every time I was consulted, I found myself unable to specify which 
medical treatment stands out from the rest at fighting against the acute renal colic. 
So honestly, a bit of ignorance and a lot of curiosity about fairly demonstrated data 
on the treatment of the acute renal colic is what encouraged me to research on this 
subject for my end-of-career project. Through the shaping of the project, other 
important matters came along, such as the economic impact of this illness or the 
standard procedures for its diagnosis. In the following lines, I´ll present what I 
consider the highlights about the renal colic, in other words, what I consider 
everyone must have in mind, fresh-baked, before diving further into this project. 
1.1. DEFINITION & PHYSIOPATHOLOGY: 
Renal calculi consist of crystal aggregates that deposit in the collecting ducts. 
Urinary stones arise because of the breakdown of a delicate balance between 
two opposing conditions: solubility and precipitation of salts, as kidneys must 
conserve water, but must excrete materials that have low solubility (1, 2). 
Additionally, urine contains substances such as citrate, pyrophosphate and 
glycoproteins that act as a protective mechanism, inhibiting crystallization. 
However, when urine becomes supersaturated with insoluble materials, 
because excretion rate is excessive and/or because water conservation is 
extreme, crystals form and may grow and aggregate to form a stone (2). 
So, nephrolithiasis is a disease that presents an increased urinary concentration 
of stone-forming salts and urine volume is a major determinant of the 
concentration of this lithogenic factors. Fluid intake is the main determinant of 
urine volume and therefore, as several observational studies (3-5) and a 
randomized controlled trial (6) have demonstrated, higher fluid intake reduces 
the risk of stone formation. Also, a prospective trial affirms that increased 
water intake also prolongs the average interval between recurrences (7). 
2 
1.2. PREVALENCE: 
Kidney stone disease is a common malady, affecting nearly 1 in 11 individuals 
in the US at some point in their lives and there is evidence that the number of 
those who have had a stone is rising (8), with at least 50% of individuals 
experiencing another stone within 10 years of the first occurrence (9). 
Historically, kidney stones have occurred more commonly in men than in 
women, although the gender gap in stone disease is closing (10-12). 
The reasons for the observed rise in stone disease among women are not 
certain, but the impact of obesity, a known risk factor for kidney stones, was 
found to be greater in women than in men (13). In fact, obesity is an 
independent risk factor for urinary calculi, particularly in women (14), reason 
why weight loss is desirable in these patients. Additionally, the beneficial 
effect of dietary moderation in reducing the risk of recurrent stones was 
demonstrated by Hoskings and co-workers, who found a reduction in stone 
recurrence rate among 108 idiopathic calcium oxalate stone formers who were 
encouraged to maintain a high fluid intake and avoid “dietary excess” (15). 
1.3. ECONOMIC IMPACT: 
Symptomatic urolithiasis manifests robustly in the practice of the Emergency 
Department (ED) physician, with a significant economic impact that echoes 
beyond the ED visit. It has been reported that over 8´8% of the United States 
population will be affected by this malady, and when treatment costs, sick days 
from work and third-party payments are considered, costs around $2.1 billion 
per year to the US economy alone (8, 11, 16, 17). Sadly, no article was found 
on the economic impact of the renal colic in this country, not even in the Intern 
resident book from the Spanish Association of Urology (18). 
1.4. SYMPTOMATOLOGY: 
Renal colic from an obstructing calculus presents classically with sudden-
onset, severe and sharp pain localized to the flank, which increases over the 
following 20-60 minutes, with radiation to the lower abdomen, groin or 
genitals. It is often accompanied by nausea and vomiting. Urinary symptoms, 
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most commonly frequency and urgency with low voided volumes, are common 
in distal ureteral stones (19). Other possible symptoms are pain on micturition, 
strangury and/or interruption of urine flow (1, 2). However, not all patients 
presenting with flank pain have urinary calculi, so an important aspect of the 
initial evaluation is to search for other potential diagnoses (Table 1) (20). 
 
 
Table 1. Differential Diagnosis for Urinary Calculi. 
 
CLINICAL CLUES SUGGESTED DIAGNOSIS 
Anorexia, nausea, vomiting Obstructing urinary calculi, bowel disease 
Dysuria UTI, urinary calculi, interstitial cystitis 
Fever, chills Viral o bacterial illness 
Hematuria (microscopic or gross) Urinary calculi, urothelial tumor, UTI, BPH, renal mass 
Hemodynamic instability Nonspecific findings of shock (including possible sepsis) 
Inability to get comfortable Urinary calculi, peritonitis 
Pain and tenderness 
 Abdominal pain 
 Flank pain (sharp, extreme 
pain with sudden onset) 
 Flank tenderness 
 
 Groin pain (scrotal, labial) 
 Penile or pelvic pain 
 Suprapubic tenderness 
 
Tachycardia 
 
Urinary frequency 
 
Small renal calculi, nonurologic etiology (GI origin) 
Urinary calculi, musculoskeletal spasm 
 
Urinary calculi, musculoskeletal inflammation, 
pyelonephritis 
Ureteral calculi, hernia, testicular mass 
Ureteral calculi, urethritis, prostatitis 
UTI, interstitial cystitis, prostatitis, urinary calculi, peritonitis 
 
Nonspecific response to pain 
 
UTI, ureteral calculi, BPH 
 
UTI = Urinary Tract Infection; BPH = Benign Prostatic Hyperplasia. 
 
 
1.5. DIAGNOSIS: 
A typical work-up includes a thorough history and physical examination, 
serum chemistry and complete blood count, urinalysis, and an imaging study. 
Typical laboratory findings are presented in Table 2 (20). 
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Table 2. Clinical Clues to the Diagnosis of Urinary Calculi. 
 
EVALUATION POSSIBLE FINDINGS 
Laboratory evaluations 
Complete blood cell count Leukocytosis with struvite calculi 
Serum chemistry Elevation in creatinine levels with obstructing calculi; hypokalemia and 
hyperchloremia with Renal Tubular Acidosis; elevated serum calcium 
levels with parathyroid disease 
Serum parathyroid 
hormone levels 
Elevated in hyperparathyroidism 
Urinalysis Microscopic or gross hematuria; acidic urine; alkaline urine (with struvite 
calculi); pyuria; crystals from involved calculi 
24-hour analysis Elevated urinary calcium, oxalate, and sodium levels; decreased urinary 
volume and citrate levels 
 
 
Most patients have remediable metabolic disorders that cause stones, so the 
composition of kidney stones should be determined when possible, because 
treatment depends on stone type (Table 3) (1). Stone composition of uric acid, 
cystine or struvite implicates specific metabolic or genetic abnormalities and 
knowledge of stone composition may also help direct preventive measures (21, 
22). Regarding the metabolic testing, there are conflicting opinions in the 
literature about the adequacy of a single 24-hour urine in reliably identifying 
urinary abnormalities (23-27). In the absence of clear consensus, either one or 
two 24-hour urines may be obtained, although two collections are preferred. 
 
 
Table 3. Major Causes of Renal Stones. 
 
STONE TYPE PERCENT 
of all stonesª 
PERCENT occurrence 
of specific causesª 
CALCIUM STONES:       75-85% 
Idiopathic calciuria  _______________________ 
Hypocitraturia  ___________________________ 
Dietary hyperoxaluria  _____________________ 
Hyperuricosuria __________________________ 
Idiopathic stone disease  ___________________ 
 
 
50-55% 
20-40% 
10-30% 
20% 
20% 
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a Values are percentages of patients who form a particular type of stone and who display each specific 
cause of stones. 
 
 
Regarding imaging studies, non-contrast computed tomography (CT) has 
emerged as the most sensitive and specific modality for detecting ureteral 
calculi. Consequently, CT is frequently used in the initial diagnosis of ureteral 
calculous disease (28) and in the follow-up of known ureteral calculi before 
and after treatment. Additionally, conventional radiography and ultrasound are 
endorsed for monitoring the passage of most radiopaque stones (29). 
Ultrasound is has a relatively low sensitivity, although it is often used as the 
initial imaging test in pregnant patients with flank pain (30). Typical 
radiographic findings are presented in Table 4 (20). 
 
 
Table 4. Clinical Clues to the Diagnosis of Urinary Calculi. 
 
EVALUATION POSSIBLE FINDINGS 
Radiographic evaluations 
Abdominal, kidney and upper 
bladder radiography 
Urinary calculi larger than 2 mm may be visible 
CT (stone protocol) Nearly all calculi are visible on CT. Evaluates renal parenchyma, 
hydronephrotic changes and surrounding organs 
Intravenous pyelography Calculi visible on scout film. Delay in contrast excretion if 
obstruction is present. Calculi may appear as filling defect 
MRI Conventional MRI is not useful for imaging calculi 
Ultrasonorography Calculi appear as hyperechoic lesions that cast acoustic shadows. 
Not reliable for ureteral calculi. May demonstrate dilation of 
collecting system 
 
CT = computed tomography; MRI = magnetic resonance imaging. 
URIC ACID STONES:       5-15% 
Metabolic syndrome  ______________________ 
Gout  ___________________________________ 
Idiopathic  _______________________________ 
 
 
30% 
30% 
30% 
 
STRUVITE STONES:        5% 
 
 
CYSTINE STONES:          1% 
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1.6. TREATMENT: 
All patients should be counseled to avoid dehydration and drink copious 
amounts of water (1). An important study confirmed that increasing urine 
volume to 2.5 L per day resulted in a 50% reduction of stone recurrence 
compared with the control group (6). 
Firstly, stones not causing obstruction may be managed conservatively. We 
should provide immediate pain relief, offering a non-steroidal anti-
inflammatory drug (NSAID) as the first drug of choice (30). NSAIDs decrease 
the production of arachidonic acid metabolites, mediators of the pain response 
released by the stretch of the renal capsule due to downstream obstruction. In 
addition, they cause contraction of the afferent arterioles to the glomerulus, 
thereby decreasing hydrostatic pressure by reducing glomerular filtration rate. 
They are safer than opioids, which could cause depression of level of 
consciousness and respiratory drive. However, caution should be exercised in 
the elderly and those with renal impairment (19). 
Literature suggests that a combination approach with NSAIDs and opioids may 
be the most effective method to manage renal colic in the ED (31). This 
combination has been studied in numerous comparisons. A systematic review 
recommends parenteral NSAIDs be used as first-line therapy for patients with 
renal colic, with the use of narcotics as adjuvant or breakthrough analgesia 
(32). Paracetamol has also proved to be an effective analgesic for acute colic. 
A recent trial showed no significant difference between degree of pain control 
and time to relief between iv paracetamol and iv morphine, with fewer adverse 
effects in the paracetamol group (33). 
Moreover, Medical Expulsive Therapy (MET) may be used if needed, as it 
increases luminal diameter and inhibits smooth muscle tone in the ureter and 
ureterovesical junction. These effects have been accomplished with the use of 
steroids and NSAIDs to limit inflammation-induced narrowing of the ureteral 
caliber. This combination has commonly been used in concert with agents 
intended to relax ureteral smooth muscle to decrease painful spasm and to 
potentially dilate the upper urinary tract to decrease pain (19). 
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The presence of adrenergic receptors in the human ureter (with increasing 
density in the distal ureter), the preponderance of the α-1 subtype and the 
ability of α-blocking medication to decrease ureteral contractility are well 
established (34-36). Calcium channel blockers (CCB) have also shown relaxing 
effects on ureteral smooth muscle (37).  
Multiple studies suggest that these agents augment the stone expulsion rate 
when compared with standard therapy (38-49), although taking a closer look at 
the reliability of this studies, the efficacy of tamsulosin and MET in improving 
the spontaneous passage of kidney stones is unclear. However, given that this 
therapy is generally well tolerated and may improve the rate of expulsion of 
kidney stones, a trial of tamsulosin or nifedipine may be considered at 
discharge. Based on the literature, α1-adrenergic blockers are preferred to 
CCB, due to shorter time to stone passage and fewer adverse effects (31). 
Furthermore, if the stone passes into the ureter and does cause obstruction, it 
becomes a complicated renal colic which can reduce both glomerular filtration 
rate and renal blood flow. The indications for urgent intervention in urinary 
tract obstruction are: presence of infection or urosepsis, intractable pain and/or 
vomiting, impending acute renal failure, obstruction with a solitary or 
transplanted kidney and bilateral obstructing stones (50). 
At the Emergency Department of Cruces Universitary Hospital, urine 
derivation is practiced when urgent intervention is required, mostly with a 
single J (single end single loop) or a double J (both end single loop) catheter. If 
insufficient, a nephrostomy is carried out, with or without the infusion of an 
alkalizing treatment such as sodium bicarbonate or alkaline citrate. A 
randomized controlled trial found that ureteral catheters, ureteral stents, and 
percutaneous nephrostomy tubes are equally effective for decompressing the 
urinary tract (51). Lastly, flexible or rigid ureterorenoscopy plus intracorporeal 
lithotripsy can be used as first or second line treatment and once or more.  
Secondly, the interventional approach of nephrolithiasis usually takes place as 
second-line treatment. Therefore, I´ll simply mention it, as the bottom-line of 
this project is the acute treatment for the renal colic. Truly, advances in 
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urologic technology have rendered open surgery for stones a rare event, leaving 
three alternatives: extracorporeal shockwave lithotripsy (SWL), percutaneous 
nephrolithotomy (PNL) and ureterorenoscopy (URS) (Figures 1 and 2). In 
general terms, the main contraindications for SWL and PNL are pregnancy, 
untreated urinary tract infections, bleeding diatheses, anticoagulant therapy, 
severe obesity or skeletal malformations (only SWL)... On the other hand, URS 
has no specific contraindications, apart from those related to the general 
anesthesia and the untreated urinary tract infections (30). 
 
 
Figure 1. Treatment algorithm for renal calculi (30). 
 
 
 
*The term "Endourology" encompasses all PNL and URS interventions. 
PNL=percutaneous nephrolithotomy; RIRS=retrograde renal surgery; SWL=shockwave lithotripsy; 
URS=ureterorenoscopy. 
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Figure 2. Treatment algorithm for ureteral calculi (GR: A*) (30). 
 
 
 
SWL=shockwave lithotripsy; URS=ureterorenoscopy. 
 
 
As you read through the introduction, you can notice the wide range of 
possibilities available for the treatment of the kidney stones. In fact, while 
working on this research, I found myself diving in a vast ocean of information 
about how renal colic´s acute pain and kidney stones in general should be 
treated. As a result, I decided to search for information available and compared 
the effectiveness of two of the main approaches of this illness: the European 
protocols and the protocols followed in the USA. Finally, I´ll be focusing 
particularly on analyzing the protocol that we follow at Cruces University 
Hospital, hoping to reach some conclusions regarding its high, intermediate, or 
low effectiveness in the acute kidney stone treatment. 
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2. HYPOTHESIS / OBJECTIVES 
To frame and give shape to the end-of-career project is essential to define its 
objectives. The following are the hypothesis that´ll be the bottom line of this project: 
2.1 Searching for significant similarities and/or differences in the protocols stated 
by Europe and United States of America on the treatment of urolithiasis. For 
this, I´ll be comparing the official European Urology Association (EAU) 
guidelines on urolithiasis and the official American Urological Association 
(AUA) guidelines on medical and surgical management of kidney stones. 
 
2.2 Searching for valid, significant and current comparative studies between the 
effectiveness of either the diagnosis and the medical or surgical treatment for 
nephrolithiasis in Europe and USA. For this, I´ll be using globally recognized 
databases on health sciences. 
 
2.3 Analyzing the protocol that we follow at Cruces University Hospital for the 
diagnosis and treatment of acute kidney stone in the emergency room, and 
looking for similarities or differences with the European and the American 
guidelines on urolithiasis or other reliable sources of information. 
 
2.4 Reaching some conclusions regarding the most effective treatment for the renal 
colic in the emergency room, built upon high level of evidence data if possible. 
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3. MATERIAL AND METHODS 
This project is a Literature Review for which the main source of information was 
Cruces University Hospital´s online library service for Health sciences. This library 
allows access to a wide range of worldwide recognized databases such as Ovid, 
Clinical Access, Cochrane, Fisterra, UpToDate, Clinical Key, Micromedex, etc. 
Precisely, this investigation has been constructed through a search in Ovid database, 
which contains publications on JBI/Joanna Briggs Institute, EMBASE, MEDLINE, 
DIF/Drug Information Full text, IPA/International Pharmaceutical Abstracts, 
PsycINFO and LWW books and journals. Also, with articles from PubMed and 
information obtained from Harrison´s principles of internal medicine and Oxford 
handbook of clinical medicine. The online information was searched using 
combinations of the following key words: 
3.1 „acute‟ +„renal‟ + „colic‟ + „treatment‟ 
3.2 „renal‟ + „colic‟ + „emergency‟+ „protocols‟ 
3.3 „urolithiasis‟ + „emergency‟ + „department‟ 
3.4 „nephrolithiasis‟ + „emergency‟ + „department‟ 
3.5 „effectiveness‟ + „protocols‟ + „calculus‟ 
3.6 „management‟ + „nephrolithiasis‟ + „emergency‟ + „department‟ 
3.7 „renal‟ + „colic‟ + „medical‟+ „expulsive‟+ „therapy‟ 
3.8 „kidney‟ + „stones‟ + „medical‟ + „expulsive‟ + „therapy‟ 
3.9 „urgent‟ + „decompression‟ + „ureteral‟ +„calculi‟ 
3.10 „water‟ + „urinary‟ + „volume‟ + „nephrolithiasis‟ 
3.11 „urgent‟ + „decompression‟ + „ureteral‟ + „calculi‟ 
The studies included were published from 1972 to 2017 and recent articles were 
given highest priority because they represent the current state-of-the-art treatment. 
Meanwhile, older studies were included selectively if historically relevant or if they 
addressed issues more adequately than the more recent literature. The paper search 
was limited to the English language, although a reference from a Spanish source can 
also be found. The European Association of Urology (EAU) and American 
Urological Association (AUA) guidelines were used in order to assemble appropriate 
evidence-based reference literature. 
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The topics of these guidelines were selected based on the level of evidence A or B, as 
described by the Oxford Centre for Evidence-Based Medicine Levels. In this source, 
when sufficient evidence exists, the body of evidence for a particular clinical action 
is assigned a strength rating of A (high), B (moderate) or C (low). Additionally, the 
AUA nomenclature system links strong, moderate or conditional recommendation to 
the A, B or C levels of evidence. Also, in the absence of sufficient evidence they 
provide additional information as Clinical Principles and Expert Opinions. 
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4. RESULTS 
The main results of this bibliographic review are obtained from two of the chief 
sources of information used: the guidelines on urolithiasis from the EAU and the 
AUA. As we mentioned before, we´ll extract only the principles that are supported 
by A or B levels of evidence. These principles have been arranged in two columns, 
one for each source, so that we can easily compare the principles that describe same 
topic. Some data with lower level of evidence has also been included (grade C, 
Clinical Principles -CP- and Expert Opinions -EO), only because its comparison with 
the equivalent topic from the other source is considered relevant. For the reader´s 
convenience, this low evidence data is marked with an orange background. 
4.1 DIAGNOSIS: Imaging. 
 
European Association of Urology (EAU) 
(30) 
GR American Urological Association (AUA) 
(52) 
GR 
Following initial ultrasound assessment, use 
non-contrast-enhanced CT to confirm stone 
diagnosis in patients with acute flank pain, as 
it is superior to intravenous urography. 
A Non-contrast CT (NCCT) is the preferred 
initial imaging study for the adult patient.. 
The diagnostic accuracy of non-contrast CT 
in identifying ureteral calculi is the following: 
sensitivity 98% and specificity 97%. 
A 
In children, use ultrasound as first-line 
imaging modality when a stone is suspected. 
Perform a KUB X-ray (or low-dose non-
contrast-enhanced CT) as an alternative. 
B Renal ultrasonorography is the preferred 
initial imaging study for pediatric patients 
(<14). 
C 
Use ultrasound as the preferred method of 
imaging in pregnant women. 
A Renal ultrasonorography is the preferred 
initial imaging study for pregnant patients. 
C 
 
 
 
4.2 DIAGNOSIS: Additional testing. 
 
European Association of Urology (EAU) 
(30) 
GR American Urological Association (AUA) 
(53) 
GR 
Perform stone analysis in first-time formers 
using a validated procedure. 
A When a stone is available, clinicians should 
obtain a stone analysis at least once. 
CP 
Repeat stone analysis in patients with 
recurrent stones despite drug therapy, early 
recurrence after stone clearance or late 
recurrence after a long stone-free period. 
B Clinicians should repeat a stone analysis, 
when available, especially in patients not 
responding to treatment. 
EO 
Only high-risk stone formers (all children, 
recurrent stone formers, transplanted 
kidneys...) require specific metabolic 
evaluation after stone removal. 
A Clinicians should perform additional 
metabolic testing in high-risk or interested 
first-time stone formers and recurrent stone 
formers. 
B 
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4.3 TREATMENT: Conservative management. 
 
European Association of Urology (EAU) 
(30) 
GR American Urological Association (AUA) 
(53) 
GR 
Provide immediate pain relief in acute stone 
episodes. Whenever possible, offer a NSAID 
as the first drug of choice. E.g. metamizol. 
A   
Offer hydromorphine, pentazocine or 
tramadol as a second choice. 
C   
In patients with newly diagnosed from small 
ureteral stones, if active stone removal is not 
indicated, observe patient periodically. 
A Clinicians should obtain periodic blood testing 
to assess for adverse effects in patients on 
pharmacological therapy. 
A 
Follow-up periodically in cases where renal 
stones are not treated (initially after six 
months and then yearly, evaluating 
symptoms and stone status [either by 
ultrasound, KUB radiography or CT]). 
A Clinicians should periodically obtain follow-up 
imaging studies to asses for stone growth or 
new stone formation based on the stone 
activity (plain abdominal imaging, renal 
ultrasonography or low dose computed 
tomography [CT]) 
EO 
Offer α-blockers as MET as one of the 
treatment options, in particular for (distal) 
ureteral stones > 5 mm. 
Counsel patients regarding the controversies 
in the literature, attendant risks of MET, 
including associated side effects. Inform that 
α-blockers as MET are administered off-
label. 
A Patients with uncomplicated ureteral stones 
<10 mm should be offered observation, and 
those with distal stones of similar size should 
be offered MET with α-blockers. 
In pediatric patients with uncomplicated 
ureteral stones ≤10 mm, offer observation 
with or without MET using α-blockers. 
B 
Recommend a high fluid intake (2.5-3 L/day) 
in patients with a small urine volume. 
A Clinicians should recommend to all stone 
formers a fluid intake that will achieve a urine 
volume of at least 2.5 liters daily. 
B 
Recommend a high fluid intake (2.5-3 L/day) 
in patients with no abnormality identified in 
urine composition. 
B 
 
 
 
4.4 TREATMENT: Interventional/endoscopic management. 
 
European Association of Urology (EAU) 
(30) 
GR American Urological Association (AUA) 
(54) 
GR 
Obtain a urine culture or perform urinary 
microscopy before any treatment is planned. 
Exclude or treat urinary tract infection prior to 
endourological stone removal. 
A Clinicians are required to obtain a urinalysis 
prior to intervention. In patients with clinical or 
laboratory signs of infection, urine culture 
should be obtained. 
B 
Perform retrograde (flexible) URS if stone 
removal is essential and antithrombotic 
therapy cannot be discontinued, since it is 
associated with less morbidity. 
A Clinicians should use URS as first-line 
therapy in most patients who require stone 
intervention in the setting of uncorrected 
bleeding diatheses or who require continuous 
anticoagulation / antiplatelet therapy. 
C 
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Offer perioperative antibiotic prophylaxis to all 
patients undergoing endourological 
treatment. 
A Antimicrobial prophylaxis should be 
administered prior to stone intervention and is 
based primarily on prior urine culture results, 
the local antibiogram, and in consultation with 
the current BPS on Antibiotic Prophylaxis. 
CP 
Treatment algorithm for RENAL CALCULI (if 
indicated for active stone removal): 
I. Kidney stone: 
‐ >20mm: 1º PNL and 2º 
URS/SWL. 
‐ 10-20mm: SWL/URS/PNL 
‐ <10mm: 1º SWL/URS and 2º 
PNL. 
II. Lower pole stone: 
‐ 10-20mm: 1º SWL (if possible) 
and 2º URS/PNL. 
In complex stone cases, use open or 
laparoscopic approaches as an alternative 
B In patients who fail or are unlikely to have 
successful results with SWL and/or URS, 
clinicians may offer PNL, laparoscopic, open, 
or robotic assisted stone removal. 
C 
Treatment algorithm for URETERAL 
CALCULI (if indicated for active stone 
removal): 
III. Proximal ureteral stone: 
‐ >10mm: 1º URS and 2º SWL. 
‐ <10mm: SWL or URS. 
IV. Distal ureteral stone: 
‐ >10mm: 1º URS and 2º SWL. 
‐ <10mm: SWL or URS. 
A Clinicians should inform patients that SWL is 
the procedure with the least morbidity and 
lowest complication rate, but URS has a 
greater stone-free rate in a single procedure. 
In patients with mid or distal ureteral stones 
who require intervention (who were not 
candidates for or who failed MET), 
recommend URS as first-line therapy. For 
patients who decline URS, clinicians should 
offer SWL. 
B 
After SWL and URS, and in the presence of 
residual fragments, offer MET using an alpha-
blocker to improve fragment clearance. 
A Clinicians may prescribe α-blockers to 
facilitate stone fragment passage after SWL 
and add antimuscarinic therapy for stent 
discomfort. 
B 
Treat all uncomplicated cases of urolithiasis 
in pregnancy conservatively (except those 
that have clinical indications for intervention). 
A In pregnant patients with ureteral stones and 
well controlled symptoms, clinicians should 
offer observation as first-line therapy. 
B 
 
Moving on to the results of other influential articles included in this project, the 
Review Article named "Renal colic: current protocols for emergency presentations" 
contains quite the same information found in the EAU and the AUA guidelines 
regarding diagnosis of urolithiasis. However, in terms of its medical treatment in the 
Emergency Department (ED) it sheds some light on the guidelines that should be 
followed. This article mentions several other sources of information, some of which 
were considered relevant. We found the original articles through the bibliography 
and summarized the results in the following table (19). 
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SOURCES RESULTS 
"Systematic review of the relative efficacy of 
nonsteroidal anti-inflammatory drugs and 
opioids in the treatment of acute renal colic" 
(32). 
‐ NSAIDs achieve slightly greater reductions in pain 
scores than opioids in patients suffering from 
renal colic. 
‐ These patients are less likely to need rescue 
analgesia if treated with NSAIDs. 
‐ Opioids are associated with a higher rate of 
vomiting and other adverse effects. 
"Intravenous paracetamol versus morphine for 
renal colic in the emergency department: a 
randomized double-blind controlled trial" (33). 
‐ IV paracetamol is an effective analgesic for acute 
renal colic. 
‐ There was no significant difference between the 
degree of pain control and time to relief between IV 
paracetamol and IV morphine. 
‐ There were fewer adverse effects in the 
paracetamol group. 
"Renal colic: current protocols for emergency 
presentations" (19). 
‐ Active warming of the lower back to 42°C and 
acupuncture have also shown benefit for pain 
reduction. 
‐ Significant improvement in appropriate analgesia 
usage by simply providing the patient with written 
(instead of just verbal) instructions before 
discharge (from 40% to 71% of patients), resulting 
in increased patient satisfaction. 
Meta-analysis by European Association of 
Urology (EAU) and American Urology 
Association (AUA) to form the joint guidelines on 
urolithiasis in 2007 (55, 56). 
‐ Nifedipine was associated with a nonstatistically 
significant 9% increase in stone passage rates, 
whereas α-blockers were associated with a 
significant 29% increase in stone passage, up to a 
size of 10mm. 
“Medical expulsive therapy in adults with 
ureteral colic: a multicentre, randomized, 
placebo-controlled trial”. The SUSPEND trial in 
2015 (57). 
‐ Comparing nifedipine, tamsulosin and placebo in 
patients with a CT confirmed ureteral stone, no 
difference was observed in terms of stone 
expulsion rates or reduction in analgesia 
requirements irrespective of stone site or size. 
 
Next, we will be analyzing the protocol followed at Cruces University Hospital for 
the diagnosis and treatment of acute kidney stone in the emergency room. This 
protocol was recently carried out by the Radiology Department in order to 
standardize the use of imaging studies for patients in the Emergency Department 
(ED). If imaging study becomes mandatory, then non-contrast-enhanced ADB-PV 
CT scan is the appropriate study to be carried out. This protocol contains the 
definition of an uncomplicated renal colic as well as the alarm signs that indicate 
that´s become complicated (high fever ≥38'5ºC or septic shock/systemic infection 
signs). The rest is divided in three sections (Annex 1): 
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I. Modulating factors: 
I.I. There´s no modulating factors. 
I.II.  Solitary kidney or transplanted kidney. 
I.III.  Previous renal impairment or acute renal failure. 
I.IV.  Clinical suspicion of urinary tract obstruction (oliguria/anuria). 
I.V. Intractable pain after 1h. 
I.VI.  Abrupt pain recurrence after effective initial analgesia (readmission in <48h). 
I.VII.  Persistent nausea and vomiting. 
I.VIII.  Need for differential diagnosis: men >60 years old with left flank pain (acute 
aortic syndrome must be discarded). 
 
Each of these modulating factors can be clicked if present. The instructions to follow 
can be found next to this list, which are the following: in case there´s no modulating 
factors: do not request X-Rays or do approach Radiologist. In case of ≥1 modulating 
factor: request non-contrast-enhanced ABD-PV CT. In case previous radiopaque 
calculi history: request ABD X-Rays +/- Ultrasound. Lastly, in children 14 to 18 
years old or pregnant patients: request ABD Ultrasound (Annex 1). 
 
II. Recommended analgesia for uncomplicated renal colic: 
II.I. Begin treatment with IV dexketoprofen (50mg) and IV paracetamol (1g). 
II.II. Provide IV morphine (3mg) in case there´s no improvement. 
II.III. If nausea or vomiting, combine with primperam or yatrox. 
II.IV. Consider individual changes (if allergies, possible interactions with active 
medical treatments). 
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III. Recommendation after patient discharge: 
III.I. Regular analgesia at the treating physician´s discretion: NSAIDs + 1st and 
2nd step analgesics + weak opioid as rescue medication. 
III.II. Without modulating factors: follow up by family physician, who will decide 
further outpatient clinic checkups and supplementary tests.  
III.III. With modulating factors, refer patient to the urologist. 
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5. DISCUSSION 
 
5.1 GENERAL ASPECTS 
While comparing the EAU and the AUA guidelines on urolithiasis, there´s one 
disparity that quickly catches the reader´s eye and that is the big difference 
between the low evidence data among the principles included in the document. 
As you can see, there´s eight low evidence based principles in the AUA, versus 
only one in the EAU. In other words, the EAU generally holds best 
evidence supported principles (16 A-s, 6 B-s and only 1 C), while the AUA 
includes a big amount of low evidence based data (3 A-s, 8 B-s, 4 C-s, 2 
Clinical Principles and 2 Expert Opinions) (30, 52-54). 
5.2 DIAGNOSIS: IMAGING STUDIES 
As for the diagnosis, the non-contrast-enhanced CT (NCCT) is the 
preferred initial imaging study for the adult patient with acute flank pain. 
This is one of the most important principles included in the guidelines, which 
quickly calls our attention also because it happens to be one of the only two 
principles that share evidence level A in both EAU and AUA guidelines. On 
top of that, the AUA supports by an A level of evidence the diagnostic 
accuracy of this imaging study, which are 98% sensitivity and 97% specificity. 
On the other hand, the ultrasound should be used as the preferred first-line 
imaging modality in children and pregnant women suffering from a renal 
colic. However, this is supported by strong evidence in the EAU (B and A 
respectively) while is supported by weak evidence in the AUA (C for both). 
The reason why these analogous principles present such uneven levels of 
evidence remains unknown. 
5.3 ADDITIONAL TESTING AND MEDICAL TREATMENT 
Either with or without strong recommendation, the guidelines affirm that a 
stone analysis should be carried out in first-time stone formers, repeating it 
depending on particular circumstances. This should always be done, as the 
final composition of the stone will be shedding light on the steps to follow for 
its management and definitive treatment.  
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Additionally, the guidelines state that the metabolic evaluation is particularly 
required in high-risk stone formers, supported by strong evidence. Taking a 
closer look at this, one can wonder what being a high-risk stone former means. 
In fact, we believe that the stone analysis and the following metabolic 
testing are actually the resources that will give physicians enough 
information to categorize a patient as a high or low risk stone-former, 
reason why they should both be mandatory in all first-time stone formers. 
For instance, if we found the most common type of stones, Calcium stones, we 
will be doing further metabolic testing to search for idiopathic calciuria, 
hypocitraturia… among others. On the other hand, if we found uric acid stones, 
then we would be studying the patient´s cardiovascular risk factors, presence of 
gout… (see Table 3). 
Regarding the use of MET, the mentioned SUSPEND trial was the most 
robust, well-powered study to date and it dismissed the role of tamsulosin 
and nifedipine as part of this treatment in 2015 (57). Such was the relevance 
of this study, that the following year, "Medical Expulsive Therapy for 
Ureterolithiasis: The EAU Recommendations in 2016" was published. In it, the 
EAU explained how lots of publications over the years had supported the use 
of α-blockers as MET, although several recently published high quality, large, 
placebo-controlled randomized trials raised serious doubts about the 
effectiveness of α-blockers (58). 
Moreover, in the latest update of the EAU guidelines on urolithiasis (2017), 
strong evidence still supports the use of MET in distal ureteral stones and also 
to facilitate passage of residual fragments after SWL and URS. However, to 
this first recommendation, the EAU guidelines add a couple of principles that 
seem cautious and ambiguous at the same time. They state that patients should 
be counseled regarding controversies in the literature, associated side 
effects (hypotension being the most frequent) as well as informing them that 
α-blockers as MET are administered off-label. This couple of principles 
reflect, again, the EAU´s rectification after the SUSPEND trial came to light. 
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Furthermore, attached to these ambiguous principles, two precise footnotes can 
be found: one, that it is not known if tamsulosin harms the human fetus or if it 
is found in breast milk and two, that MET using α-blockers in children and 
during pregnancy cannot be recommended due to the limited data in this 
specific population. On the other hand, the AUA states that in pediatric 
patients with uncomplicated ureteral stones ≤10 mm, clinicians should offer 
observation with or without MET using α-blockers. This is a big disparity 
between the two sources. 
So not only in adult patients but there´s also great controversy about the use of 
MET in children, which added to the controversy raised up by the SUSPEND 
trial about the inefficacy of MET (57), generates doubt about the truthfulness 
of the original studies that supported the launching of this medication into 
market. In fact, all of this leads us to think that substantial commercial 
interests from influential pharmaceutical companies could probably be 
underneath the overcome MET fever. 
Moving on, the perioperative antibiotic prophylaxis in all patients 
undergoing endourological treatment is supported with strong evidence by 
the EAU (A level of evidence), while is supported with weak evidence by the 
AUA (Clinical Principle). The reason why these analogous principles present 
such uneven level of evidence remains unknown. However, this prophylaxis 
should be considered a must, as it is generally known that the stones have 
quite a high probability of infection and administrating the antibiotics by 
protocol could save time and money to the system, as well as potential 
complications to the patient. 
5.4 CRUCES UNIVERSITARY HOSPITAL´S PROTOCOL FOR THE 
TREATMENT OF THE RENAL COLIC IN THE EMERGENCY 
DEPARTMENT 
Overall, this protocol follows quite strictly the established European and 
American guidelines on the treatment of urolithiasis. Firstly, it declares the 
non-contrast-enhanced ABD-PV CT scan as the standardized imaging 
study. Secondly, this protocol also declares the ABD ultrasound as the 
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preferred imaging study for children and pregnant women, which meets all 
the criteria from the mentioned sources. 
Thirdly, the modulating factors included in the protocol are the so called 
standard indications for urgent intervention, which we have seen earlier in the 
“Management of kidney stones” article: presence of infection or urosepsis, 
intractable pain and/or vomiting, impending acute renal failure, obstruction 
with a solitary or transplanted kidney and bilateral obstructing stones (50). This 
protocol goes even slightly further, as it includes another indication: the need 
for a differential diagnosis in case of men over 60 years old with left flank 
pain, as we must discard an acute aortic syndrome. 
Regarding the medical treatment of the renal colic, the analgesics included in 
the protocol are IV NSAID (dexketoprofen) as the first drug of choice and 
iv paracetamol, same as stated by the EAU with an A level of evidence. As 
a second choice analgesic, the protocol includes IV morphine, even though the 
EAU supports this with a C level of evidence. Surprisingly, this protocol does 
not mention the use of α-blockers as MET, which is recommended by the 
EAU in particular for distal ureteral stones >5 mm with an A level of evidence. 
Again, this could be due to the existing controversy about the efficacy of MET, 
reflected in the SUSPEND trial as we mentioned earlier. 
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6. CONCLUSIONS 
 
6.1 GENERAL ASPECTS 
While completing the introduction of this project, the first conclusion we 
reached was that there´s a national lack of investigation on this topic. 
Regardless of how common the renal colic is among the population, no 
article could be found on the prevalence or the economic impact of this 
disease in the country. Economical data from the US was used to complete 
this project, as the country enjoys widely supported researching resources. 
However, we should again highlight the fact that the European guidelines on 
urolithiasis generally hold best evidence supported principles, while the 
AUA includes a big amount of low evidence based data, even though the 
reason for such uneven levels of evidence remains unknown. 
6.2 DIAGNOSIS: IMAGING STUDIES 
As we mentioned before, the non-contrast-enhanced CT scan has proved to 
be the most worthwhile imaging study for the diagnosis of urolithiasis, 
although it must be used rationally. Also, the ultrasound should be used as the 
preferred first-line imaging study in children and pregnant women 
suffering from a renal colic. 
6.3 ADDITIONAL TESTING AND MEDICAL TREATMENT 
The stone analysis and the metabolic testing of the patients with urolithiasis 
is a determining procedure for a more precise treatment in stone-formers. We 
realized that there is no standardized protocol for this in Cruces 
University Hospital, resulting in a random chance of performing the tests 
depending on the attending physician. We encourage the hospital to develop 
one, as this will provide a rising and spreading awareness to perform both the 
stone analysis and metabolic testing, especially between the most 
inexperienced physicians. Eventually, this would lead to a more precise 
treatment/intervention/prevention program, which would also lead to lower 
chances of recurrent renal colic, which would at the same time turn into lower 
spending rates for the system. 
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Regarding the medical treatment of the renal colic, it´s safe to affirm that we 
have found the answer to our most primitive question, the question that 
originated this project. Yes, there is an ideal treatment for the acute renal 
colic, built in fact, upon high level of evidence data. This is based on IV 
NSAIDs plus IV paracetamol, to which IV opioids such as morphine can 
be added up in case the pain is still uncontrolled. On the other hand, we 
discovered that highly accurate and reliable sources have proved MET with α-
blockers to be ineffective in the treatment of urolithiasis. 
As we have already mentioned, there´s strong evidence supporting 
perioperative antimicrobial prophylaxis to all patients undergoing 
endourological treatment. We also found that there´s no standardized 
protocol for this in Cruces University Hospital, so we encourage them to 
develop one in order to diminish the chances of mistake. 
6.4 CRUCES UNIVERSITARY HOSPITAL´S PROTOCOL FOR THE 
TREATMENT OF THE RENAL COLIC IN THE EMERGENCY 
DEPARTMENT 
With all the data found and all the comparisons made, we stand in absolute 
favor of this protocol, as it is not only based on theoretical high level of 
evidence data from reliable sources, but has also proved to be profitable in the 
long run for the applied patient´s assistance, despite the initial distrust and 
skepticism that caused. In fact, including the non-contrast-enhanced CT 
scan in this protocol has provided higher accuracy on the diagnosis of 
urolithiasis and on the consequent medical and/or interventionist/surgical 
treatment, as well as helping with the early detection of accidental 
discoveries such as cancer or metastasis in any abdominal organ.  
6.5 INTERVENTIONAL TREATMENT 
Finally, we found that SWL is the procedure with the least morbidity and 
lowest complication rate, while URS has a greater stone-free rate in a single 
procedure. Meanwhile, there´s also strong evidence supporting that PNL 
should be the initial interventional treatment of choice for large kidney stones 
(>20mm), while smaller kidney stones or lower pole stones should ideally 
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be treated with SWL. Meanwhile, there´s also strong evidence supporting 
larger ureteral stones (>10mm, no matter if higher or lower location) should 
be initially approached with URS, while smaller stones (<10mm, no matter 
if higher or lower location) should be first treated with SWL. 
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7. RECOMMENDATIONS TO THE HEALTH SERVICE 
 
7.1 Research on the outcomes of any intervention should be more encouraged in all 
hospital services, as a way to guarantee that the right measures are being put 
into practice for the system´s improvement. In our case, we recommend 
researching on the effectiveness of Medical Expulsive Therapy (MET) 
treatment for urolithiasis in our community. 
 
7.2 Create protocols for the metabolic testing as part of the renal colic´s 
general study, as well as for the prophylactic administration of 
antimicrobial therapy in patients with urolithiasis that require intervention. 
Ideally, after creating and applying the protocols, research should be 
encouraged in order to evaluate the outcomes. 
 
7.3 Cruces Universitary Hospital´s protocol for the treatment of the renal 
colic in the emergency department has proved to be effective, so its 
integration in other health institutes should be considered. For this, 
Emergency Departments should be supplied with CT scans in order to 
facilitate their use as the everyday diagnostic study. 
  
27 
8. BIBLIOGRAPHY 
(1) Asplin JR, Coe FL, Favus MJ. Nephrolithiasis. In: Longo DL et al., editors. 
Harrison´s principles of internal medicine Vol.2. 18th ed. USA: McGraw-Hill; 2011. 
p. 2382-87. 
(2) Murray L, Wilkinson I, Turmezei T, Chung CK. Oxford handbook of clinical 
medicine. 7th ed. Oxford: Oxford University Press; 2007. 
(3) Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary 
calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 
1993; 328(12):833-8.  
(4) Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison 
of dietary calcium with supplemental calcium and other nutrients as factors affecting 
the risk for kidney stones in women. Ann Intern Med 1997; 126(7):497-504. 
(5) Curhan GC, Willett WC, Knight EL, Stampfer MJ. Dietary factors and the risk of 
incident kidney stones in younger women (Nurses' Health Study II). Arch Intern Med 
2004; 164(8):885-91. 
(6) Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary 
volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year 
randomized prospective study. J Urol 1996; 155(3):839-43. 
(7) Qiang W, Ke Z. Water for preventing urinary calculi. Cochrane Database Syst 
Rev 2004; (3): CD004292. 
(8) Scales CD Jr, Smith AC, Hanley JM, Saigal CS. Prevalence of kidney stones in 
the United States. Eur Urol 2012; 62(1):160-5. 
(9) Uribarri J, Oh MS, Carroll HJ. The first kidney stones. Ann Intern Med 1989; 
111(12):1006-9. 
(10) Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends 
in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 
2003; 63(5):1817-23. 
28 
(11) Pearle MS, Calhoun EA, Curhan GC. Urologic diseases in America project: 
urolithiasis. J Urol 2005; 173(3):848-57.  
(12) Scales CD Jr, Curtis LH, Norris RD, Springhart WP, Sur RL, Schulman KA et 
al. Changing gender prevalence of stone disease. J Urol 2007; 177(3):979-82. 
(13) Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of 
kidney stones. JAMA 2005; 293(4):455-62. 
(14) Curhan GC, Willett WC, Rimm EB, Speizer FE, Stampfer MJ. Body size and 
risk of kidney stones. J Am Soc Nephrol 1998; 9(9):1645-52. 
(15) Hosking DH, Erickson SB, Van den Berg CJ, Wilson DM, Smith LH. The stone 
clinic effect in patients with idiopathic calcium urolithiasis. J Urol 1983; 130(6): 
1115-8. 
(16) Saigal CS, Joyce G, Timilsina AR. Urologic diseases in America project: Direct 
and indirect costs of nephrolithiasis in an employed population: opportunity for 
disease management? Kidney Int 2005; 68(4):1808-14. 
(17) Brown J. Diagnostic and treatment patterns for renal colic in US emergency 
departments. Int Urol Nephrol 2006; 38(1):87–92. 
(18) Carballido J, Franco A, Gausa L, Robles JE, Sánchez M, Server G, et al. 
Etiología y fisiopatología de la litiasis. In: Castiñeiras J. Libro del Residente de 
Urología. 1º ed. Madrid: Grupo ENE Publicidad, S.A.; 2007. p.751-765. 
(19) Leveridge M, D'Arcy FT, O'Kane, D, Ischia JJ, Webb DR, Bolton DM et al. 
Renal colic: current protocols for emergency presentations. EJEM 2016; 23(1): 2-7. 
(20) Pietrow PK, Karellas ME. Medical management of common urinary calculi. Am 
Fam Physician 2006; 1; 74(1):86-94. 
(21) Pak CY, Poindexter JR, Adams-Huet B, Pearle MS. Predictive value of kidney 
stone composition in the detection of metabolic abnormalities. Am J Med 2004; 
115(1): 26-32. 
29 
(22) Kourambas J, Aslan P, Teh CL, Mathias BJ, Preminger GM. Role of stone 
analysis in metabolic evaluation and medical treatment of nephrolithiasis. J Endourol 
2001; 15(2):181-6. 
(23) Castle SM, Cooperberg MR, Sadetsky N, Eisner BH, Stoller ML. Adequacy of a 
single 24-hour urine collection for metabolic evaluation of recurrent nephrolithiasis. 
J Urol 2010; 184(2): 579-83. 
(24) Pak CY, Peterson R, Poindexter JR. Adequacy of a single stone risk analysis in 
the medical evaluation of urolithiasis. J Urol 2001; 165(2): 378-81. 
(25) Parks JH, Goldfisher E, Asplin J, Coe FL. A single 24-hour urine collection is 
inadequate for the medical evaluation of nephrolithiasis. J Urol 2002; 167(4):1607-
12. 
(26) Healy KA, Hubosky SG, Bagley DH. 24-Hour Urine collection in the metabolic 
evaluation of stone formers: Is one study adequate? J Endourol 2013; 27(3):374-8. 
(27) Nayan M, Elkoushy MA, Andonian S. Variations between two 24-hour urine 
collections in patients presenting to a tertiary stone clinic. Can Urol Assoc J 2012; 
6(1):30-3.  
(28) Hyams ES, Korley FK, Pham JC, Matlaga BR. Trends in imaging use during the 
emergency department evaluation of flank pain. J Urol 2011; 186(6): 2270-4.  
(29) Fulgham PF, Assimos DG, Pearle MS, Preminger GM. Clinical Effectiveness 
Protocols for Imaging in the Management of Ureteral Calculous Disease: AUA 
Technology Assessment. J Urol 2013; 189:1203-1213. 
(30) Turk C, Neisius A, Petrik A, Seitz C, Skolarikos A, Tepeler A, et al. [Internet]. 
Guidelines on Urolithiasis. The Netherlands: European Association of Urology; 2017 
[access on February the 2nd, 2018]. Available at: 
http://uroweb.org/guideline/urolithiasis/ 
 
30 
(31) Graham A, Luber S, Wolfson AB. Urolithiasis in the Emergency Department. 
Emerg Med Clin North Am. 2011; 29(3):519-538. 
(32) Holdgate A, Pollock T. Systematic review of the relative efficacy of 
nonsteroidal anti-inflammatory drugs and opioids in the treatment of acute renal 
colic. BMJ 2004; 328(7453):1401. 
(33) Serinken M, Eken C, Turkcuer I, Elicabuk H, Uyanik E, Schultz CH. 
Intravenous paracetamol versus morphine for renal colic in the emergency 
department: a randomised double-blind controlled trial. Emerg Med J 2012; 
29(11):902–5. 
(34) Kubacz GJ, Catchpole BN. The role of adrenergic blockade in the treatment of 
ureteral colic. J Urol 1972; 107(2):949–51. 
(35) Park HK, Choi EY, Jeong BC, Kim HH, Kim BK. Localizations and 
expressions of alpha-1A, alpha-1B and alpha-1D adrenoceptors in human ureter. 
Urol Res 2007; 35(6):325–9. 
(36) Nakada SY. Tamsulosin: ureteric motility. BJU Int 2008; 101(9):1061–2. 
(37) Floyd RV, Borisova L, Bakran A, Hart CA, Wray S, Burdyga TV. Morphology, 
calcium signaling and mechanical activity in human ureter. J Urol 2008; 180(1):398–
405. 
(38) Preminger GM. Editorial comment. The value of intensive medical management 
of distal ureteral calculi in an effort to facilitate spontaneous stone passage. Urology 
2000; 56(1):582-3. 
(39) Porpiglia F, Destefanis P, Fiori C, Fontana D. Effectiveness of nifedipine and 
deflazacort in the management of distal ureter stones. Urology 2000; 56(4):579-82. 
(40) Dellabella M, Milanese G, Muzzonigro G. Efficacy of tamsulosin in the medical 
management of juxtavesical ureteral stones. J Urol. 2003; 170(6 Pt 1):2202-5. 
31 
(41) Saita A, Bonaccorsi A, Marchese F, Condorelli SV, Motta M. Our experience 
with nifedipine and prednisolone as expulsive therapy for ureteral stones. Urol Int. 
2004; 1(72):43-5. 
(42) Dellabella M, Milanese G, Muzzonigro G. Medical-expulsive therapy for distal 
Ureterolithiasis: randomized prospective study on role of corticosteroids used in 
combination with tamsulosin-simplified treatment regimen and health-related quality 
of life. Urology 2005; 66(4):712-5. 
(43) Dellabella M, Milanese G, Muzzonigro G. Randomized trial of the efficacy of 
tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal 
ureteral calculi. J Urol 2005; 174(1):167-72. 
(44) Porpiglia F, Ghignone G, Fiori C, et al. Nifedipine versus tamsulosin for the 
management of lower ureteral stones. J Urol 2004; 172(2):568-71. 
(45) Hollingsworth JM, Rogers MA, Kaufman SR, Bradford TJ, Saint S, Wei JT et 
al. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet 2006; 
368(9542):1171-9. 
(46) Yilmaz E, Batislam E, Basar MM, Tuglu D, Ferhat M, Basar H. The comparison 
and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J 
Urol 2005; 173(6):2010-2. 
(47) Parsons JL, Hergan LA, Sakamoto K, Lakin C. Efficacy of alpha-blockers for 
the treatment of ureteral stones. J Urol 2007; 177(3):983-7. 
(48) Agrawal M, Gupta M, Gupta A, Agrawal A, Sarkari A, Lavania P. Prospective 
and randomized trial comparing efficacy of alfuzosin and tamsulosin in management 
of lower ureteral stones. Urology 2009; 73(4):706-9. 
(49) Ferre RM, Wasielewski JM, Strout TD, Perron AD. Tamsulosin for ureteral 
stones in the emergency department: a randomized, controlled trial. Ann Emerg Med 
2009; 54(3):432-9. 
32 
(50) Miller NL, Lingeman JE. Management of kidney stones. BMJ. 2007; 334(7591): 
468-72. 
(51) Pearle MS, Pierce HL, Miller GL, Summa JA, Mutz JM, Petty BA et al. Optimal 
method of urgent decompression of the collecting system for obstruction and 
infection due to ureteral calculi. J Urol. 1998; 160(4):1260-4. 
(52) Fulgham PF, Assimos DG, Pearle MS, Preminger GM. [Internet]. Clinical 
Effectiveness Protocols For Imaging In The Management Of Ureteral Calculous 
Disease: AUA Technology Assessment. Maryland: American Urological 
Association; 2012 [access on February the 2nd, 2018]. Available at: 
http://www.auanet.org/guidelines/imaging-for-ureteral-calculous-disease 
(53) Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga 
BR, et al. [Internet]. Medical Management of Kidney Stones. Maryland: American 
Urological Association; 2014 [access on February the 2nd, 2018]. Available at: 
http://www.auanet.org/guidelines/medical-management-of-kidney-stones-(2014) 
(54) Assimos DG, Krambeck A, Miller NL, Monga M, Murad MH, Nelson CP, et al. 
[Internet]. Surgical Management of Stones: AUA/Endourology Society Guideline. 
Maryland: American Urological Association; 2016 [access on February the 2nd, 
2018]. Available at: 
http://www.auanet.org/guidelines/surgical-management-of-stones-
(aua/endourological-society-guideline-2016) 
(55) European Association of Urology. European Association of Urology: stone 
guidelines 2007: European Association of Urology. Available at:  
http://uroweb.org/wp-content/uploads/22-Urolithiasis_LR.pdf. 
(56) American Urological Association. American Urological Association guidelines: 
ureteral stones 2007: American Urological Association. Available at: 
https://www.auanet.org/education/guidelines/ureteral-calculi.cfm. 
33 
(57) Pickard R, Starr K, MacLennan G, Lam T, Thomas R, Burr J et al. Medical 
expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-
controlled trial. Lancet 2015; 386:341–9. 
(58) Türk C, Knoll T, Seitz C, Skolarikos A, Chapple C, McClinton S. Medical 
Expulsive Therapy for Ureterolithiasis: The EAU Recommendations in 2016. Eur 
Urol. 2017; 71(4): 504-7. 
 
  
ANNEXES 
 
ANNEX 1 
 
 
 
 
